本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lexeo Therapeutics

4.16
+0.03000.73%
盤後4.160.00000.00%16:10 EDT
成交量:61.95萬
成交額:258.66萬
市值:3.41億
市盈率:-3.63
高:4.22
開:4.16
低:4.09
收:4.13
52周最高:10.99
52周最低:3.99
股本:8,204.63萬
流通股本:5,122.95萬
量比:0.71
換手率:1.21%
股息:- -
股息率:- -
每股收益(TTM):-1.1457
每股收益(LYR):-1.8634
淨資產收益率:-46.76%
總資產收益率:-27.59%
市淨率:1.45
市盈率(LYR):-2.23

資料載入中...

2024/06/28

重要事件披露

Form 8-K - Current report
2024/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/11

SEC問詢函

Form CORRESP - Correspondence
2024/04/09

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

重要事件披露

Form 8-K - Current report
2023/12/18

重要事件披露

Form 8-K - Current report
2023/12/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]